An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...

Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

Objectives Traumatic and non-traumatic spinal cord injury produce neurodegeneration across the entire neuraxis. However, the spatiotemporal dynamics of spinal cord grey and white matter ...

Just three games after returning from an earlier injury, Kaprizov will miss at least four weeks after undergoing surgery to repair a lower-body injury he suffered against the Chicago Blackhawks on ...

Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York City ...

aDivision of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada bDivision of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, ON, Canada ...

Our study applied the Angiopep-2 peptide to spinal cord injury to enhance the targeting of injured cells, and successfully construct engineered extracellular vesicles that can target the spinal cord ...

Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi’an 710032, ...